KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Cash from Operations (2017 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Cash from Operations for 18 consecutive years, with 70504000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations rose 158.6% year-over-year to 70504000.0; the TTM value through Mar 2026 reached 714896000.0, up 1617.54%, while the annual FY2025 figure was 524080000.0, 6405.1% up from the prior year.
  • Cash from Operations hit 70504000.0 in Q1 2026 for Alnylam Pharmaceuticals, down from 163555000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 359412000.0 in Q3 2023 and bottomed at 171193000.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 8773764.71, with a median of 58986000.0 recorded in 2023.
  • Year-over-year, Cash from Operations crashed 217.71% in 2024 and then soared 643.84% in 2025.
  • Alnylam Pharmaceuticals' Cash from Operations stood at 131978000.0 in 2022, then surged by 77.42% to 29795000.0 in 2023, then plummeted by 217.71% to 94662000.0 in 2024, then soared by 272.78% to 163555000.0 in 2025, then tumbled by 56.89% to 70504000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 70504000.0, 163555000.0, and 325109000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.